• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Spontaneous tumors of the European hamster -Cricetus cricetus L.-.
 
  • Details
  • Full
Options
1989
Journal Article
Title

Spontaneous tumors of the European hamster -Cricetus cricetus L.-.

Other Title
Spontantumoren des Europäischen Hamsters - Cricetus cricetus L
Abstract
The incidence and spectrum of spontaneously occuring neoplasms was evaluated in 285 European hamsters (strain Mhh:EPH) ranging in age between 1 and 5 years. The mean lifespan of the 107 male and 135 female hamsters examined amounted to 122 and 135 weeks, respectively. The overall incidence of tumor-bearing animals was 51,2% (males:57,9%, females:47,2%). Malignant tumours were more frequent than benign neoplasms and affected more males than females. Neoplasms of the haematopoietic/lymphoreticular system were the most common tumours (males:16,8%, females:13,5%). In males, these were followed in a decreasing order of incidence by pheochromocytomas (15,9), malignant schwannomas (8,4%) and tumours of the prostate (6,5%). In females, pheochromocytomas as well as granulosa cell tumours were the second commonest tumour types (6,2% each), followed by malignant schwannomas (5,1%). Other tumours did not exceed the 5% incidence level. Two unusual rare tumours were a locally invasive cementoblastom a arising in the maxilla and a carcinosarcoma of the skin with components of a squamous cell carcinoma and a neurofibrosarcoma. The results of the study are compared with data on the Syrian and Chinese hamster.
Author(s)
Ernst, H.
Kunstyr, I.
Mohr, U.
Rittinghausen, S.
Journal
Zeitschrift für Versuchstierkunde  
Language
English
ITA  
Keyword(s)
  • carcinogenicity

  • European hamster

  • neoplasm

  • pathology

  • spontaneous disease

  • tumor

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024